BRIGHTCOVE
25.6.2020 15:12:07 CEST | Business Wire | Press release
Brightcove Inc. (NASDAQ: BCOV), the world’s leading video technology platform, today announced Brightcove Virtual Event Experiences , a solution that allows organizations to deliver high-quality virtual events featuring bold, interactive experiences. Responding to a crucial market need, Brightcove Virtual Event Experiences enables organizations to host events with market-leading video technology to engage with audiences securely and reliably around the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200625005507/en/
The adoption of video communications in enterprise organizations is growing at a rapid pace. According to the recent Brightcove Global Video Index , in the first quarter of 2020, video views among enterprise companies increased by 91% year over year, with preliminary year-over-year data from April and May showing viewing increases of nearly 80% and 54%, respectively. Along with this adoption, many in-person events and meetings are moving to online video. With no timetable for the return of large-scale, in-person conferences and events, marketing and event professionals are looking for an in-person alternative, and they are turning to Brightcove for guidance. Recently, Brightcove technology has helped power critical B2B, B2C, and arts/entertainment events, helping organizations scale quickly, easily, and securely while reaching new audiences across the globe, including:
- ServiceNow Knowledge 2020
- DocuSign MomentumLive
- Talkdesk® Opentalk 2020 Virtual
- NAB Show Express with over 40,000 industry professionals accessing the event since its launch
- The Dropkick Murphys’ Streaming Outta Fenway concert joined by Bruce Springsteen with over 9 million live and on-demand views to date, raising over $700,000 for charity
- The Metropolitan Opera's At Home Gala, with more than 40 artists participating from around the world, was watched by more than 750,000 people
The need to engage with customers and prospects is as critical as ever, and organizations expect to deliver innovative and measurable experiences for their audiences in order to maintain communication and engagement. The Brightcove Virtual Events Experience solution empowers companies to take immediate action to ensure that their essential in-person events can continue virtually.
Features include:
- Branding and User Experience: Control the viewer’s experience and surrounding content by hosting on Brightcove.
- Increased Value for Sponsors: Demonstrate value to sponsors and exhibitors by offering integrated ads, complete with measurable and tangible analytics.
- Quality and Global Scale: Enable streaming video to global audiences in a secure environment.
- Security : Configure a variety of security options beyond password protection and geo-blocking, including SSO and integration with user management solutions.
- Expertise and support: Engage with Brightcove’s customer experience team and support organization to meet business objectives.
“Like most B2B companies, we had to quickly pivot from an in-person event to a virtual customer conference when COVID-19 hit. Our strategy was to embrace the remote reality but also to create an experience that felt like a performance and developed a sense of community,“ said Kathie Johnson, Chief Marketing Officer, Talkdesk. “To do this, we selected Brightcove as the platform and leveraged its integration partner Pigeonhole for the live polling and social interaction. One analyst who compared B2B customer conferences stated Opentalk 2020 virtual ‘struck the best balance of event duration, content, and engagement.’ The development process with Brightcove was seamless and the response to our program has been extremely positive.”
“The pandemic is video’s evolutionary moment, and as a result, video is now at the forefront of how we communicate with others, how we conduct business, and is enabling us to stay connected even when physically apart,” said Sara Larsen, Chief Marketing Officer, Brightcove. “Events are a place for information sharing, learning, business building, and networking. Now, more than ever, we need events to flourish and connect us in a virtual video experience. Brightcove Virtual Events Experiences allows organizations to deliver exceptional virtual events quickly and securely, without sacrificing the attendee experience. With this solution, we’re not only helping our customers adapt to the changing landscape but also allowing them to stay connected with their audiences with an engaging, innovative video-driven digital experience.”
For more information on Brightcove Virtual Event Experiences, visit: https://www.brightcove.com/en/solutions/virtual-event
About Brightcove Inc. (NASDAQ: BCOV)
We are the people behind the world’s leading video technology platform. With our award-winning technology and services, we help organizations in more than 70 countries meet business challenges and create strategic opportunities by inspiring, entertaining, and engaging their audiences through video.
Since Brightcove was established in 2004, we have consistently pushed boundaries to create a platform for people who are serious about video: one that is robust, scalable, and intuitive. Benefiting from a global infrastructure, unrivalled customer support, an extensive partner ecosystem, and relentless investment in R&D, Brightcove video sets the standard for professional grade video management, distribution, and monetization. To learn more, visit www.brightcove.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200625005507/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 01:35:00 CEST | Press release
~ Creating Climate Solutions and New Market Opportunities through Source-Specific CO2 Emission and Uptake Monitoring via Satellite Constellation and Aircraft ~ Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Cap
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
